Allworth Financial LP Cytek Biosciences, Inc. Transaction History

Allworth Financial LP

$16.1 Billion
Q3 2024

A detailed history of Allworth Financial LP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 98 shares of CTKB stock, worth $643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$643

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 23, 2024	BUY	$4.73 - $6.73 $463 - $659	98 New	98 $0
Q4 2023 Jan 24, 2024	BUY	$4.1 - $9.51 $168 - $389	41 New	41 $0

Others Institutions Holding CTKB

# of Institutions

134

Shares Held

71.7M

Call Options Held

400

Put Options Held

Black Rock Inc. New York, NY

17.1M
Shares

$112 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$77.4 Million
0.0% of portfolio
Brown Capital Management LLC Baltimore, MD

9.49M
Shares

$62.4 Million
1.15% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

6.66M
Shares

$43.7 Million
0.85% of portfolio
State Street Corp Boston, MA

4.17M
Shares

$27.4 Million
0.0% of portfolio

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $884M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account